Popvax
(POPVAX PRIVATE LIMITED)
Mumbai
Founded in 2021
About Popvax
PopVax is an Indian biotechnology startup that is building a novel second-generation platform for broadly protective vaccines via computationally driven antigen design, starting with an open source booster vaccine candidate that is intended to protect against the entire sarbecovirus species.
Incubators & Accelerators of Popvax
Public Links of Popvax
Frequently Asked Questions (FAQ)
Where is Popvax's headquarters?
Popvax is based out of Mumbai.
When was Popvax founded?
Popvax was founded in the year 2021.
What is the legal name of Popvax?
The legal name of Popvax is Popvax Private Limited.
Who are the founders of Popvax?
Popvax is founded by Sahaj Govindarajan Sankaran and Soham Govindarajan Sankaran.
Which Incubators & Accelerators supported Popvax?
What are the focus areas of Popvax?
Who are Popvax's competitors?
Possible competitors of Popvax may include Acintya Solutions Private Limited, Bionline Diagnostics, Dalter and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
